Upgrades: ArcelorMittal ($MT) upgraded to Overweight from Neutral at JPMorgan Array Technologies ($ARRY) upgraded to Outperform from Neutral at Mizuho, Target: $5 Bank of America ($BAC) upgraded to Outperform from Neutral at Baird, Target: $62 BorgWarner ($BWA) upgraded to Buy from Neutral at BofA, Target: $85 Brighthouse Financial ($BHF) upgraded to Neutral from Underweight at …
Read in context ›Hemab Therapeutics Holdings, Inc. Stock (COAG)
Track Hemab Therapeutics Holdings, Inc. stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
COAG
Hemab Therapeutics Holdings, Inc.
general
$38.65
â–² +13.99 (+55.21%) past year
Market Cap
$1.81B
P/E Ratio
—
1Y Return
+55.21%
EPS (TTM)
—
Read the latest TheStreet Pro articles mentioning Hemab Therapeutics Holdings, Inc., including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
0 articlesNo articles mentioning COAG yet.
Daily Diary Mentions
1 mentionUpgrades, Downgrades and New Research Coverage